Urinary tract infections caused by multi-drug resistant proteus mirabilis: Risk factors and clinical outcomes

Infection

Volumn 38, Issue 1, 2010, Pages 41-46

  Cohen Nahum, K ^a   Saidel Odes, L ^a   Riesenberg, K ^a   Schlaeffer, F ^a   Borer, A ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CEPHALOSPORIN; EXTENDED SPECTRUM BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; OUTCOME ASSESSMENT; PREVALENCE; PROGNOSIS; PROTEUS MIRABILIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEUS INFECTIONS; PROTEUS MIRABILIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; URINARY TRACT INFECTIONS; URINE; YOUNG ADULT;

EID: 77549088105     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-009-8460-5     Document Type: Article

References (21)

1. National Nosocomial Infections Surveillance 2003 NNIS system report, data summary from January 1992 through June 2003. Issued August 2003 Am J Infect Control. 31 481 498 10.1016/j.ajic.2003.09.002 (Pubitemid 37533217)
2. E.M. D'Agata 2004 Rapidly rising prevalence of nosocomial multidrugresistant, gram-negative bacilli: a 9-year surveillance study Infect Control Hosp Epidemiol 25 842 846 10.1086/502306 15518026 (Pubitemid 40036760)
3. J.A. Karlowsky M.E. Jones C. Thornsberry I.R. Friedland D.F. Sahm 2003 Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001 Antimicrob Agents Chemother 47 1672 1680 10.1128/AAC.47.5.1672-1680.2003 1:CAS:528: DC%2BD3sXjslGhtbg%3D 12709339 (Pubitemid 36548553)
4. S.R. Lockhart M.A. Abramson S.E. Beekmann G. Gallagher S. Riedel D.J. Diekema J.P. Quinn G.V. Doern 2007 Antimicrobial resistance among Gram-negative bacilli causing infections in intensive are unit patients in the United States between 1993 and 2004 J Clin Microbiol 45 3352 3359 10.1128/JCM.01284-07 17715376 (Pubitemid 47585661)
5. E.J. Giamarellos-Bourboulis E. Papadimitriou N. Galanakis A. Antonopoulou T. Tsaganos K. Kanellakopoulou H. Giamarellou 2006 Multidrug resistance to antimicrobials as a predominant factor influencing patient survival Int J Antimicrob Agents 27 476 481 10.1016/j.ijantimicag.2005.12.013 1:CAS:528:DC%2BD28XltFCgtr0%3D 16707252 (Pubitemid 43767087)
6. C. de Champs R. Bonnet D. Sirot C. Chanal J. Sirot 2000 Clinical relevance of Proteus mirabilis in hospital patients: a two year survey J Antimicrob Chemother 45 537 539 10.1093/jac/45.4.537 10747835
7. A. Endimiani F. Luzzaro G. Brigante M. Perilli G. Lombardi G. Amicosante G.M. Rossolini A. Toniolo 2005 Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases Antimicrob Agents Chemother 49 2598 2605 10.1128/AAC.49.7.2598- 2605.2005 1:CAS:528:DC%2BD2MXlvFSmtbc%3D 15980325 (Pubitemid 40917567)
8. F. Luzzaro M. Perilli G. Amicosante G. Lombardi R. Belloni A. Zollo C. Bianchi A. Toniolo 2001 Properties of multidrug-resistant, ESBL-producing proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations Int J Antimicrob Agents 17 131 135 10.1016/S0924-8579(00) 00325-3 1:CAS:528:DC%2BD3MXnsVSmtg%3D%3D 11165117 (Pubitemid 32101567)
9. C. Chanal R. Bonnet C. De Champs D. Sirot R. Labia J. Sirot 2000 Prevalence of beta-lactamases among 1,072 clinical strains of proteus mirabilis: a 2-year survey in a French hospital Antimicrob Agents Chemother 44 1930 1935 10.1128/AAC.44.7.1930-1935.2000 1:CAS:528:DC%2BD3cXksVKksbY%3D 10858357 (Pubitemid 30422951)
10. E.P. Hyle A.D. Lipworth T.E. Zaoutis I. Nachamkin N.O. Fishman W.B. Bilker X. Mao E. Lautenbach 2005 Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species Clin Infect Dis. 40 1317 1324 10.1086/429239 1:CAS:528:DC%2BD2MXktlajsr0%3D 15825035 (Pubitemid 40570242)
11. J.R. Hernández L. Martínez-Martínez A. Pascual A.I. Suárez E.J. Perea 2000 Trends in the susceptibilities of proteus mirabilis isolates to quinolones J Antimicrob Chemother 45 407 408 10.1093/jac/45.3.407 10702570
12. R. Saito S. Okugawa W. Kumita K. Sato T. Chida N. Okamura K. Moriya K. Koike 2007 Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients Clin Microbiol Infect 13 1204 1206 10.1111/j.1469-0691.2007.01826.x 1:STN:280:DC%2BD2snmsFGntw%3D%3D 17850340 (Pubitemid 350056127)
13. A.W. Bauer W.M. Kirby J.C. Sherris M. Turck 1966 Antibiotic susceptibility testing by a standardized single disk method Am J Clin Pathol 45 493 496 1:STN:280:DyaF287htV2isA%3D%3D 5325707
14. K.A. Gordon R.N. Jones 2003 SENTRY Participant Groups (Europe, Latin America, North America): Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America: results from the SENTRY Antimicrobial Surveillance Program (2000) Diagn Microbiol Infect Dis 45 295 301 10.1016/S0732-8893(02)00467-4 1:CAS:528:DC%2BD3sXjtlWksbc%3D 12730002 (Pubitemid 36555682)
15. D.J. Farrell I. Morrissey D. De Rubeis M. Robbins D. Felmingham 2003 A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection Infection 46 94 100 10.1053/jinf.2002.1091 1:STN:280:DC%2BD3s7itVCqtQ%3D%3D (Pubitemid 36221655)
16. T.E. Johansen M. Cek K.G. Naber L. Stratchounski M.V. Svendsen P. Tenke 2006 PEP and PEAP-study Investigators; Board of the European Society of Infections in Urology: Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies Int J Antimicrob Agents 28 [Suppl1] S91 107 10.1016/j.ijantimicag.2006.05.005 1:CAS:528:DC%2BD28XotVyku7k%3D 16829052 (Pubitemid 44163148)
17. J.W. Warren J.H. Tenney J.M. Hoopes H.L. Muncie W.C. Anthony 1982 A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters J Infect Dis 146 719 723 1:STN:280: DyaL3s%2FlvVanug%3D%3D 6815281
18. D.K. Byarugaba 2004 A view on antimicrobial resistance in developing countries and responsible risk factors Int J Antimicrob Agents 24 105 110 10.1016/j.ijantimicag.2004.02.015 1:CAS:528:DC%2BD2cXmt1WgsL8%3D 15288307 (Pubitemid 38993687)
19. D.L. Paterson R.A. Bonomo 2005 Extended-spectrum β-Lactamases: a clinical update Clin Microbiol Rev 18 657 686 10.1128/CMR.18.4.657-686.2005 1:CAS:528:DC%2BD2MXht1Wrsr%2FE 16223952 (Pubitemid 41504510)
20. M.J. Schwaber S. Navon-Venezia D. Schwartz Y. Carmeli 2005 High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae Antimicrob Agents Chemother 49 2137 2139 10.1128/AAC.49.5. 2137-2139.2005 1:CAS:528:DC%2BD2MXktFSnu7Y%3D 15855548 (Pubitemid 40631641)
21. Z. Samra O. Ofir Y. Lishtzinsky L. Madar-Shapiro J. Bishara 2007 Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel Int J Antimicrob Agents 30 525 529 10.1016/j. ijantimicag.2007.07.024 1:CAS:528:DC%2BD2sXht12isbbE 17931835 (Pubitemid 350064465)